---
title: "DUALITYBIO initiates listing guidance"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/264626895.md"
description: "According to the official website of the China Securities Regulatory Commission, DUALITYBIO officially launched its listing guidance on November 5, 2025, with CITIC Securities Co., Ltd. serving as the guidance institution"
datetime: "2025-11-06T11:20:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264626895.md)
  - [en](https://longbridge.com/en/news/264626895.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264626895.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/264626895.md) | [English](https://longbridge.com/en/news/264626895.md)


# DUALITYBIO initiates listing guidance

According to the official website of the China Securities Regulatory Commission, DUALITYBIO officially launched its listing guidance on November 5, 2025, with CITIC Securities Co., Ltd. serving as the guidance institution

### 相關股票

- [CITIC Securities Co., Ltd. (600030.CN)](https://longbridge.com/zh-HK/quote/600030.CN.md)
- [CITIC SEC (06030.HK)](https://longbridge.com/zh-HK/quote/06030.HK.md)
- [DUALITYBIO-B (09606.HK)](https://longbridge.com/zh-HK/quote/09606.HK.md)

## 相關資訊與研究

- [CITIC Issues Supplemental Note Clarifying Status of 2024–2025 Financial Results](https://longbridge.com/zh-HK/news/280776066.md)
- [Hon Hai's US Unit Buys Foxconn Assembly for $296 Million; Shares Drop 3%](https://longbridge.com/zh-HK/news/281130288.md)
- [TSMC's Supply Squeeze Through 2028 Could Be This Chipmaker's Big Break As AI Demand From Nvidia, Apple Surges](https://longbridge.com/zh-HK/news/281141442.md)
- [Henlius Wins Key EMA Backing for Cancer Drug Serplulimab in Europe](https://longbridge.com/zh-HK/news/280997570.md)
- [Luzhou Xinglu Water Seeks Shareholder Nod for Connected Sludge Disposal Deal](https://longbridge.com/zh-HK/news/281238947.md)